These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33738428)
1. Macular pigment optical density in central serous chorioretinopathy. Polat Gultekin B; Sahli E Ther Adv Ophthalmol; 2021; 13():2515841421997195. PubMed ID: 33738428 [TBL] [Abstract][Full Text] [Related]
2. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Kim SW; Oh J; Kwon SS; Yoo J; Huh K Retina; 2011 Oct; 31(9):1904-11. PubMed ID: 21878855 [TBL] [Abstract][Full Text] [Related]
3. One-year follow-up of choroidal and macular thickness in acute non-treated central serous chorioretinopathy. Orduña-Azcona J; Pérez-Fernández E; Modamio L; De Manuel-Triantafilo S; Rodríguez-Hernández CF; Gili P Clin Exp Optom; 2023 Jan; 106(1):47-55. PubMed ID: 35157808 [TBL] [Abstract][Full Text] [Related]
4. Macular pigment density changes in central serous chorioretinopathy. Tudosescu R; Alexandrescu CM; Istrate SL; Vrapciu A; Ciuluvica RC; Voinea LM Rom J Ophthalmol; 2018; 62(3):222-227. PubMed ID: 30505992 [No Abstract] [Full Text] [Related]
5. [Pathophysiology of macular diseases--morphology and function]. Iida T Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310 [TBL] [Abstract][Full Text] [Related]
6. Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Gulkas S; Sahin O Eur J Ophthalmol; 2020 Sep; 30(5):1053-1060. PubMed ID: 31256613 [TBL] [Abstract][Full Text] [Related]
7. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy. Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183 [TBL] [Abstract][Full Text] [Related]
8. MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES. Gergely R; Kovács I; Schneider M; Resch M; Papp A; Récsán Z; Nagy ZZ; Ecsedy M Retina; 2017 Jun; 37(6):1084-1091. PubMed ID: 27627749 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography. Demirel S; Değirmenci MFK; Batıoğlu F; Özmert E Eur J Ophthalmol; 2021 Jan; 31(1):184-193. PubMed ID: 31684767 [TBL] [Abstract][Full Text] [Related]
10. Macular pigment optical density in central serous chorioretinopathy. Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108 [TBL] [Abstract][Full Text] [Related]
11. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082 [TBL] [Abstract][Full Text] [Related]
12. OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy. Borrelli E; Battista M; Sacconi R; Gelormini F; Querques L; Grosso D; Vella G; Bandello F; Querques G Am J Ophthalmol; 2021 Mar; 223():129-139. PubMed ID: 33342759 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of acute central serous chorioretinopathy on optical coherence tomography - a retrospective study. Aqil A; Mehmood A; Moin M; Abid K J Pak Med Assoc; 2020 Oct; 70(10):1834-1837. PubMed ID: 33159763 [TBL] [Abstract][Full Text] [Related]
14. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome. Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838 [TBL] [Abstract][Full Text] [Related]
15. Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy. Goktas A Eye (Lond); 2014 Dec; 28(12):1431-6. PubMed ID: 25233823 [TBL] [Abstract][Full Text] [Related]
16. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy. Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370 [TBL] [Abstract][Full Text] [Related]
17. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Guo J; Tang W; Liu W; Chang Q; Xu G Retina; 2021 Jan; 41(1):199-207. PubMed ID: 32251241 [TBL] [Abstract][Full Text] [Related]
18. Does microperimetry have a prognostic value in central serous chorioretinopathy? Roisman L; Ribeiro JC; Fechine FV; Lavinsky D; Moraes N; Campos M; Farah ME Retina; 2014 Apr; 34(4):713-8. PubMed ID: 23975001 [TBL] [Abstract][Full Text] [Related]